Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Human safety, immunogenicity and pharmacokinetics reported for h5G1.1-scFV

Nov. 3, 1997

No Comments

Pharmacokinetics of anti-CD11b MAb in patients undergoing aneurysm repair

Nov. 3, 1997

No Comments

Clevidipine lowers MAC of anesthetic in animal study

Nov. 3, 1997

No Comments

Effect of AMPA antagonist GYKI-52466 on oxygen balance in ischemic cortex

Nov. 3, 1997

No Comments

Phase II results promising for E-047/1 following CABG

Nov. 3, 1997

No Comments

Antitumor activity of LC-9018 correlated with cytokine production

Oct. 28, 1997

No Comments

Preclinical studies on FK-317 presented at cancer meeting

Oct. 28, 1997

No Comments

DAB-720: a new EGF receptor TK inhibitor from Mitsubishi Chemical

Oct. 28, 1997

No Comments

Mechanism of action and in vivo antitumor efficacy reported for CS-682

Oct. 28, 1997

No Comments

Novel antiangiogenic agent with oral activity in animal model of breast cancer

Oct. 28, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Conferences, BioWorld Science
RSS

Human safety, immunogenicity and pharmacokinetics reported for h5G1.1-scFV

Pharmacokinetics of anti-CD11b MAb in patients undergoing aneurysm repair

Clevidipine lowers MAC of anesthetic in animal study

Effect of AMPA antagonist GYKI-52466 on oxygen balance in ischemic cortex

Phase II results promising for E-047/1 following CABG

Antitumor activity of LC-9018 correlated with cytokine production

Preclinical studies on FK-317 presented at cancer meeting

DAB-720: a new EGF receptor TK inhibitor from Mitsubishi Chemical

Mechanism of action and in vivo antitumor efficacy reported for CS-682

Novel antiangiogenic agent with oral activity in animal model of breast cancer

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Conferences, BioWorld Science RSS

Conferences, BioWorld Science
RSS